Difference between revisions of "SOCR News UMich CCC HnN Retreat 2018"
(→Slidedeck) |
(→Outline) |
||
(2 intermediate revisions by the same user not shown) | |||
Line 2: | Line 2: | ||
==Logistics== | ==Logistics== | ||
+ | [[Image:SOCR_Logo_April_2018.png|150px|thumbnail|right| [http://socr.umich.edu SOCR Resource] ]] | ||
* '''Event''': 2018 [https://www.mcancer.org/head-and-neck-cancer Head and Neck Oncology Program Retreat] | * '''Event''': 2018 [https://www.mcancer.org/head-and-neck-cancer Head and Neck Oncology Program Retreat] | ||
* '''Place/Time''': Friday May 11, 2018, 7:30AM-4:00PM, University of Michigan, Pierpont Commons (East Room), 2101 Bonisteel Blvd, Ann Arbor, MI 48109. | * '''Place/Time''': Friday May 11, 2018, 7:30AM-4:00PM, University of Michigan, Pierpont Commons (East Room), 2101 Bonisteel Blvd, Ann Arbor, MI 48109. | ||
* '''Presenter''': [http://www.umich.edu/~dinov/ Ivo D Dinov] | * '''Presenter''': [http://www.umich.edu/~dinov/ Ivo D Dinov] | ||
+ | |||
+ | == Program== | ||
+ | <center> | ||
+ | {| class="wikitable" | ||
+ | |- | ||
+ | ! Time | ||
+ | ! Title | ||
+ | ! Presenter | ||
+ | |- | ||
+ | | 7:30-8:00 || Breakfast || | ||
+ | |- | ||
+ | | 8:00-8:15 ||History of HNOP and Future Plans || Tom Carey/ Mark Prince | ||
+ | |- | ||
+ | | 8:15-8:30 || Multi-parametric MRI for assessment of Progression UMCC 2013.062 Phase 2 randomized trial in Poor Prognosis HNSCC || Michele Mierswa | ||
+ | |- | ||
+ | | 8:30-8:45 ||Imaging Findings in UMCC 2013.062 || Yue Cao | ||
+ | |- | ||
+ | | 8:45-9:00 || Effects of definitive ChemoRT on neck function || David Lipps/Michele Mierswa/Paul Swiecicki/Sean Smith | ||
+ | |- | ||
+ | | 9:00-9:15 || Individualized survival Prediction for Patients with OPSCC +/- HPV || Peter Hawkins | ||
+ | |- | ||
+ | | 9:15-9:30 ||Therapeutic Targeting of adenoid cystic Carcinoma stem cells || Jacques Nor | ||
+ | |- | ||
+ | | 9:30-10:45 || Lipidomic profiling identifies phospholipase A2 as a novel therapy || Mark Cohen | ||
+ | |- | ||
+ | | 10:00-10:15 ||Coffee Break || | ||
+ | |- | ||
+ | | 10:15-10:30 ||Molecular profiling of sinonasal Papillomas: Mechanisms of oncogenesis and malignant progression || Aaron Udager | ||
+ | |- | ||
+ | | 10:35-10:45 ||Identification of HPV-human fusion Transcripts in HNSCC cell lines and tumors || Lisa Pinatti | ||
+ | |- | ||
+ | | 10:30-10:45 ||Expressed HNSCC mutations by HPV status in a Michigan Cohort || TingTing Qin/Maureen Sartor | ||
+ | |- | ||
+ | | 10:45-11:00 ||5-hydroxymethylation captures the heterogeneity in keratinization || Siyu Liu/Maureen Sartor | ||
+ | |- | ||
+ | | 11:00-11:15 ||Using small molecule profiling to identify effective combination Therapies in HNSCC || Nicole Michmerhuizen | ||
+ | |- | ||
+ | | 11:15-11:30 ||Update on the Low Risk OPSCC Surgical Trial || Matt Spector | ||
+ | |- | ||
+ | | 11:30-11:45 ||Predicting wound healing in salvage surgery: SPY, MRI and TSH || Matt Spector | ||
+ | |- | ||
+ | | 11:45-12:00 ||Update on the MiOtoSeq Study || Collin Brummel/Chad Brenner | ||
+ | |- | ||
+ | | 11:40-11:50 ||MiOto genetics and Clinical analysis || Keith Casper/Nick | ||
+ | |- | ||
+ | | 11:50-12:00 ||Investigating mechanisms of PD-L1 regulation in UMSCC cell lines || Jackie Mann | ||
+ | |- | ||
+ | | 12:00 -1:00 || LUNCH || All | ||
+ | |- | ||
+ | | 1:00-1:15 || TBA || Nisha D’Silva | ||
+ | |- | ||
+ | | 1:15-1:30 || Mucoepidermoid Cancer RNASeq and ctDNA analysis || Chad Brenner | ||
+ | |- | ||
+ | | 1:30-1:45 ||Loss of E2 promotes cisplatin resistance in HPV16 Positive HNSCC || Josh Smith | ||
+ | |- | ||
+ | | 1:45-2:00 || Exploratory, Confirmatory, & Predictive Big Cancer Data Analytics || Ivo Dinov | ||
+ | |- | ||
+ | | 2:00-2:15 ||Genetic analysis of HPV+ OPSCC || Chad Brenner | ||
+ | |- | ||
+ | | 2:15-2:30 ||Coffee Break || | ||
+ | |- | ||
+ | | 2:30-3:15 ||Head and Neck/Endocrine Clinical Trials Update Inhibition in HNSCC || Frank Worden Shannon Musser | ||
+ | |- | ||
+ | | 3:15-3:30 || Physical and Cognitive Function, Symptom Distress and Quality of Life in Head and Neck Cancer || Moira Visovatti | ||
+ | |- | ||
+ | | 3:30-3:45 ||Novel Therapeutics and Emerging Biomarkers in Head & Neck Cancers || Paul Sweicicki | ||
+ | |- | ||
+ | | 3:00-4:00 ||Overview and Discussion of Future translational projects || All | ||
+ | |} | ||
+ | </center> | ||
==Outline== | ==Outline== | ||
− | + | We developed computational statistics and machine learning methods for H&N Cancer analytics. Three applications of the new methods on the H&N cancer dataset (n~350) include: (1) predicting univariate clinical outcomes (e.g., cancer staging), (2) processing unstructured clinical notes and medication data, and, (3) generating machine-learning models of association. | |
− | We | ||
==Slidedeck== | ==Slidedeck== | ||
[http://socr.umich.edu/docs/uploads/2018/Dinov_Predictive_Cancer_HnN_Analytics_2018_Retreat.pdf Dr. Dinov's slides are available here]. | [http://socr.umich.edu/docs/uploads/2018/Dinov_Predictive_Cancer_HnN_Analytics_2018_Retreat.pdf Dr. Dinov's slides are available here]. | ||
+ | |||
==References== | ==References== |
Latest revision as of 08:12, 18 May 2018
Contents
SOCR News & Events: Exploratory, Confirmatory, & Predictive Big Cancer Data Analytics
Logistics
- Event: 2018 Head and Neck Oncology Program Retreat
- Place/Time: Friday May 11, 2018, 7:30AM-4:00PM, University of Michigan, Pierpont Commons (East Room), 2101 Bonisteel Blvd, Ann Arbor, MI 48109.
- Presenter: Ivo D Dinov
Program
Time | Title | Presenter |
---|---|---|
7:30-8:00 | Breakfast | |
8:00-8:15 | History of HNOP and Future Plans | Tom Carey/ Mark Prince |
8:15-8:30 | Multi-parametric MRI for assessment of Progression UMCC 2013.062 Phase 2 randomized trial in Poor Prognosis HNSCC | Michele Mierswa |
8:30-8:45 | Imaging Findings in UMCC 2013.062 | Yue Cao |
8:45-9:00 | Effects of definitive ChemoRT on neck function | David Lipps/Michele Mierswa/Paul Swiecicki/Sean Smith |
9:00-9:15 | Individualized survival Prediction for Patients with OPSCC +/- HPV | Peter Hawkins |
9:15-9:30 | Therapeutic Targeting of adenoid cystic Carcinoma stem cells | Jacques Nor |
9:30-10:45 | Lipidomic profiling identifies phospholipase A2 as a novel therapy | Mark Cohen |
10:00-10:15 | Coffee Break | |
10:15-10:30 | Molecular profiling of sinonasal Papillomas: Mechanisms of oncogenesis and malignant progression | Aaron Udager |
10:35-10:45 | Identification of HPV-human fusion Transcripts in HNSCC cell lines and tumors | Lisa Pinatti |
10:30-10:45 | Expressed HNSCC mutations by HPV status in a Michigan Cohort | TingTing Qin/Maureen Sartor |
10:45-11:00 | 5-hydroxymethylation captures the heterogeneity in keratinization | Siyu Liu/Maureen Sartor |
11:00-11:15 | Using small molecule profiling to identify effective combination Therapies in HNSCC | Nicole Michmerhuizen |
11:15-11:30 | Update on the Low Risk OPSCC Surgical Trial | Matt Spector |
11:30-11:45 | Predicting wound healing in salvage surgery: SPY, MRI and TSH | Matt Spector |
11:45-12:00 | Update on the MiOtoSeq Study | Collin Brummel/Chad Brenner |
11:40-11:50 | MiOto genetics and Clinical analysis | Keith Casper/Nick |
11:50-12:00 | Investigating mechanisms of PD-L1 regulation in UMSCC cell lines | Jackie Mann |
12:00 -1:00 | LUNCH | All |
1:00-1:15 | TBA | Nisha D’Silva |
1:15-1:30 | Mucoepidermoid Cancer RNASeq and ctDNA analysis | Chad Brenner |
1:30-1:45 | Loss of E2 promotes cisplatin resistance in HPV16 Positive HNSCC | Josh Smith |
1:45-2:00 | Exploratory, Confirmatory, & Predictive Big Cancer Data Analytics | Ivo Dinov |
2:00-2:15 | Genetic analysis of HPV+ OPSCC | Chad Brenner |
2:15-2:30 | Coffee Break | |
2:30-3:15 | Head and Neck/Endocrine Clinical Trials Update Inhibition in HNSCC | Frank Worden Shannon Musser |
3:15-3:30 | Physical and Cognitive Function, Symptom Distress and Quality of Life in Head and Neck Cancer | Moira Visovatti |
3:30-3:45 | Novel Therapeutics and Emerging Biomarkers in Head & Neck Cancers | Paul Sweicicki |
3:00-4:00 | Overview and Discussion of Future translational projects | All |
Outline
We developed computational statistics and machine learning methods for H&N Cancer analytics. Three applications of the new methods on the H&N cancer dataset (n~350) include: (1) predicting univariate clinical outcomes (e.g., cancer staging), (2) processing unstructured clinical notes and medication data, and, (3) generating machine-learning models of association.
Slidedeck
Dr. Dinov's slides are available here.
References
- SOCR Publications
- Dinov, ID, 2018. Data Science and Predictive Analytics: Biomedical and Health Applications using R, Springer, Computer Science, ISBN 978-3-319-72346-4.
- Data Science and Predictive Analytics (DSPA) Website: http://predictive.space
- SOCR Funding
- SOCR Home page: http://www.socr.umich.edu
Translate this page: